Literature DB >> 1540336

Hormonal aspects of breast cancer. Growth factors, drugs and stromal interactions.

R Clarke1, R B Dickson, M E Lippman.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1992        PMID： 1540336     DOI： 10.1016/1040-8428(92)90062-u

Source DB:  PubMed          Journal:  Crit Rev Oncol Hematol        ISSN： 1040-8428            Impact factor:   6.312


× No keyword cloud information.
  33 in total

Review 1.  Estrogen responsiveness and control of normal human breast proliferation.

Authors:  E Anderson; R B Clarke; A Howell
Journal:  J Mammary Gland Biol Neoplasia       Date:  1998-01       Impact factor: 2.673

Review 2.  The properties of high-dimensional data spaces: implications for exploring gene and protein expression data.

Authors:  Robert Clarke; Habtom W Ressom; Antai Wang; Jianhua Xuan; Minetta C Liu; Edmund A Gehan; Yue Wang
Journal:  Nat Rev Cancer       Date:  2008-01       Impact factor: 60.716

3.  Identification of BCAR3 by a random search for genes involved in antiestrogen resistance of human breast cancer cells.

Authors:  T van Agthoven; T L van Agthoven; A Dekker; P J van der Spek; L Vreede; L C Dorssers
Journal:  EMBO J       Date:  1998-05-15       Impact factor: 11.598

4.  Positive regulation of normal and tumoral mammary epithelial cell proliferation by fibroblasts in coculture.

Authors:  C Gache; Y Berthois; P M Martin; S Saez
Journal:  In Vitro Cell Dev Biol Anim       Date:  1998-04       Impact factor: 2.416

5.  Estrogen induction of the cyclin D1 promoter: involvement of a cAMP response-like element.

Authors:  M Sabbah; D Courilleau; J Mester; G Redeuilh
Journal:  Proc Natl Acad Sci U S A       Date:  1999-09-28       Impact factor: 11.205

6.  Estrogen-dependent cyclin E-cdk2 activation through p21 redistribution.

Authors:  M D Planas-Silva; R A Weinberg
Journal:  Mol Cell Biol       Date:  1997-07       Impact factor: 4.272

Review 7.  Hormone resistance, invasiveness, and metastatic potential in breast cancer.

Authors:  R Clarke; E W Thompson; F Leonessa; J Lippman; M McGarvey; T L Frandsen; N Brünner
Journal:  Breast Cancer Res Treat       Date:  1993       Impact factor: 4.872

Review 8.  Tamoxifen resistance in breast cancer: elucidating mechanisms.

Authors:  L C Dorssers; S Van der Flier; A Brinkman; T van Agthoven; J Veldscholte; E M Berns; J G Klijn; L V Beex; J A Foekens
Journal:  Drugs       Date:  2001       Impact factor: 9.546

9.  Elevated plasma transforming growth factor-beta 1 levels in breast cancer patients decrease after surgical removal of the tumor.

Authors:  F M Kong; M S Anscher; T Murase; B D Abbott; J D Iglehart; R L Jirtle
Journal:  Ann Surg       Date:  1995-08       Impact factor: 12.969

Review 10.  Timing of dietary fat exposure and mammary tumorigenesis: role of estrogen receptor and protein kinase C activity.

Authors:  L Hilakivi-Clarke; R Clarke
Journal:  Mol Cell Biochem       Date:  1998-11       Impact factor: 3.396
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.